Placebo-Controlled, Randomized, Parallel Group, Multiple-Dose Study to Evaluate the Effects of CP-481,715 on Clinical Response and Cellular Infiltration Following Contact Allergen Challenge to the Skin of Nickel Allergic Subjects.
Sponsor study identifier
interventional
48
2 countries
5
Study Start
September 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
To evaluate the suitability of contact allergy as a method for the evaluation of c-chemokine receptor-1 antagonist.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2003
Date type not reportedThis date has not been verified as actual or estimated.
August 30, 2005
Actual (reported)September 1, 2005
Actual (reported)October 2005
Date type not reportedThis date has not been verified as actual or estimated.
Effect of CP-481,715 on clinical response and cell infiltration after nickel challenge
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pfizer Investigational Site
Ann Arbor, Michigan, 48109-0314, United States
Pfizer Investigational Site
New York, New York, 10032, United States
Pfizer Investigational Site
Austin, Texas, 78759, United States
Pfizer Investigational Site
Bryan, Texas, 77802, United States
Pfizer Investigational Site
Hellerup, 2900, Denmark
Pfizer CT.gov Call Center
Pfizer
First Submitted
August 30, 2005
First Posted
September 1, 2005
Study Start
September 2003
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
October 2005
Date type not reportedStudy of the Intradermal Injection of rHuPH20 or Placebo in Participants With Nickel Allergic Contact Dermatitis
Contact the study team to confirm eligibility.
This date has not been verified as actual or estimated.
Last Updated
July 25, 2006
Record last verified: 2005-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: